Management of orthostatic hypotension relies on a combination of non-pharmacological measures and pharmacological agents like fludrocortisone and midodrine to improve symptoms and quality of life, while balancing the risk of supine hypertension.
No takes yet. Share an insight, caveat, or question.
May support pharmacological OH management for QoL gains with monitoring; leaves open optimal strategies via prospective trials.
Maule et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: